Verkazia (cyclosporine) is an eye medication used to ease swelling and itchiness on the surface of the eye from a rare allergic condition called vernal keratoconjunctivitis (VKC). It's FDA approved for use in both adults and children ages 4 years and up. The dose is to place one drop in the affected eye(s) 4 times a day. The most common side effects include temporary eye pain after applying the medication.
Verkazia (cyclosporine) is a calcineurin inhibitor. Calcineurin is a protein in your body that raises inflammation, including your eyes.
Although it's not clear how Verkazia (cyclosporine) works in the eyes, it's thought that the medication lowers eye inflammation, which helps to relieve symptoms of vernal keratoconjunctivitis (VKC).
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
How to use Verkazia (cyclosporine):
It depends. In clinical studies, symptoms like itchiness might start to lessen within the first month of starting Verkazia (cyclosporine). But it can take up to 4 months or longer for you to get the full benefit from the medication. Keep in mind that your provider might ask you to stop using Verkazia (cyclosporine) once signs and symptoms of VKC are resolved.
Yes, Verkazia (cyclosporine) can be used safely long term, but it's important to talk to your provider first to determine how long you should use it for. In clinical studies, people have used this medication for up to 1 year. Talk to your provider about whether it's safe for you to continue to use Verkazia (cyclosporine).
No. Verkazia (cyclosporine) is considered a calcineurin inhibitor, not a steroid medication.
No, Verkazia (cyclosporine) is not the same as Restasis (cyclosporine), even though both contain the same active ingredient. Verkazia (cyclosporine) is used to treat VKC, which is a rare eye condition that causes itching, blurry vision, and light sensitivity. On the other hand, Restasis (cyclosporine) is used to treat dry eyes. Also, Verkazia (cyclosporine) is typically used 4 times a day until signs and symptoms of VKC are gone. But Restasis (cyclosporine) is used typically twice a day for at least 3 to 6 months, and maybe even longer. Discuss with your provider about which medication is right for you.
No, you shouldn't use Verkazia (cyclosporine) to treat dry eyes. Verkazia (cyclosporine) is only FDA approved as a treatment for VKC, a rare allergic eye condition. But, there are other cyclosporine eye drops such as Restasis (cyclosporine) or Cequa (cyclosporine) that are approved by the FDA to treat dry eye. These eye drops have different strengths and instructions compared to Verkazia (cyclosporine). Let your provider know what symptoms you have so they can decide which eye drop is a better option for you.
Verkazia (cyclosporine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Don't let the tip of the vial touch the eye, eyelid, fingers, or other surfaces. Doing so can contaminate Verkazia (cyclosporine) and cause serious harm to the eye, such as infection and vision loss.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 0.3ml of 0.1% | 400 vials | $1,764.25 | $4.41 |
Each drop of Verkazia (cyclosporine) contains 0.1% of cyclosporine